Name: SLDB Balance Sheet - Solid Biosciences Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

SLDB - Solid Biosciences Inc.

USD | NASDAQ | Healthcare

SLDB Balance Sheet - Solid Biosciences Assets & Debt | Ledgeburg

(in millions of USD)	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash And Short Term Investments
Cash And Equivalents	59.9	80.2	74.0	155.4	119.1	154.7	76.0	86.4	52.1	7.7
Restricted Cash	1.2	0.0	-	-	-	-	-	-	0.1	0.2
Short Term Investments	-	-	-	-	-	-	-	-	-	-
Cash And Short Term Investments	59.9	80.2	74.0	155.4	119.1	154.7	76.0	86.4	52.1	7.7
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	16.4	8.4	6.1	5.9
Non-Current Assets
Property, Plant & Equipment Gross	18.4	17.8	19.4	20.6	18.1	16.9	16.4	12.4	2.9	-
Accumulated Depreciation	14.2	13.0
Current Liabilities
Accounts Payable	3.2	4.2	2.0	3.2	4.5	3.3	7.1	3.7	5.1	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	19.1	21.2	22.7
Common Equity
Common Stock	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	-	-
Additional Paid In Capital	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16
Cash And Short Term Investments
Cash And Equivalents	297.1	59.9	61.4	138.9	210.6	80.2	64.4	95.9	117.6	74.0	49.0	91.6	164.6	155.4	48.8

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	15.5	16.4	8.7	10.5	6.5	8.4	8.4	7.3	8.1	6.1	5.5	7.3	5.1	5.9	5.1	7.3	18.5	14.7
Other Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Assets Held For Sale	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Assets	396.8	205.5	244.9	278.6	313.4	157.3	179.5	197.6	214.2	129.7	148.3	167.5	190.6	219.6	147.5	170.4

Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	19.4	19.4	19.2	19.0	19.5	20.6	15.7	19.9	18.5	18.1	17.8	17.3	16.9	16.9	16.8	16.7	16.7	16.4	15.4	15.1	14.6	12.4	9.4	7.5	5.1	2.9	-	-	-	-
Accumulated Depreciation	-	-	-	-	-	-	-	-	13.1	12.7	12.1	11.6	10.9	11.0	9.4	13.1	12.4
Property,Plant & Equipment Net	3.9	4.2	4.4	4.3	4.5	4.7	5.1	5.4	6.4	6.6	7.0	7.4	8.6	9.7	6.3	6.8	6.1
Long Term Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity Method Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Goodwill	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Right Of Use Assets	21.3	21.9	22.5	23.1	23.7	24.3	24.9	25.5	26.1	26.5	27.2	27.8	28.3	28.9	28.4	28.9
Deferred Tax Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Assets	0.2	0.2	0.2	0.3	0.3	0.4	0.5	0.5	0.2	0.2	0.3	0.2	0.2	0.2	0.4	0.4	0.1
Total Non-Current Assets	26.1	27.1	29.1	29.7	30.5	31.4	32.3	33.4	-	35.2	-	-	-	-	-	-	-
Total Assets	422.9	232.5	273.9	308.3	343.9	188.7	211.8	231.0	248.7	164.9	184.7	204.7	229.6	260.3	184.5	208.5	207.6

Current Liabilities
Accounts Payable	5.6	3.2	8.4	4.7	6.4	4.2	3.5	2.5	1.7	2.0	1.9	3.0	5.6	3.2	5.2	5.1	4.8	4.5	4.1	3.0	3.2	3.3	4.1	2.8	2.4	7.1	3.2	5.6	5.4	3.7	4.8	3.7	5.8	5.1	-	-	-	-
Short Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.0	-	6.2
Operating Lease Liabilities Current	2.2	2.1	2.0	1.9	1.9	1.8	1.7	1.7	1.7	1.9	1.8	1.9	1.9	1.9	1.1	0.0
Accrued Expenses	19.2	18.9	19.1	16.5	14.6	19.9	13.2	9.9	10.3	10.2	11.5	10.5	12.4	16.7	10.3	16.1	9.4	9.5
Other Current Liabilities	-	-	-	-	-	-	-	-	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.2
Total Current Liabilities	30.3	33.5	36.3	29.8	28.8	30.3	22.9	14.7	14.3	14.5	15.8	15.9	20.3	22.5	16.9

Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	18.5	19.1	19.6	20.2	20.7	21.2	21.6	22.1	22.5	22.7	23.2	23.6	23.9	24.3	24.3	24.5
Deferred Revenue Non-Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Tax Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pension Obligations	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	0.1	-	-	-
Total Non-Current Liabilities	18.5	19.1	19.6	20.2	20.7	21.2	22.0	23.0	-	23.9	-	-	-	-	-	-
Total Liabilities	48.8	52.5	56.0	50.0	49.4	51.4	44.8	37.7	38.0	38.5	40.4	41.0	45.8	48.6	41.2	46.3

Common Equity
Common Stock	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-	-
Additional Paid In Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	(1,014.5)	(957.8)	(908.0)	(862.2)	(822.7)	(783.5)	(740.9)	(708.1)	(683.1)	(658.8)	(638.4)	(617.4)	(592.8)	(562.7)	(547.6)	(527.2)	(502.1)
Accumulated Other Comprehensive Income	(0.0)	0.1	0.0	(0.0)	0.0	0.0	0.1	(0.0)	(0.0)	0.0	0.0	0.0	0.0	(0.1)	(0.2)	(0.1)
Treasury Stock	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Stockholders Equity	374.1	180.0	217.9	258.3	294.5	137.2	167.0	193.2	210.7	126.5	144.4	163.7	183.8	211.7	143.3	162.2	185.5
Total Equity	374.1	180.0	217.9	258.3	294.5	137.2	167.0	193.2	210.7	126.5	144.4	163.7	183.8	211.7	143.3	162.2	185.5	208.2